These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 2590559)

  • 1. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of transforming growth factors by human colon cancer lines.
    Coffey RJ; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor production by human colon carcinoma cell lines.
    Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
    Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
    Rizzino A; Ruff E; Rizzino H
    Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
    Carr BI; Hayashi I; Branum EL; Moses HL
    Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
    Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
    Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
    Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
    J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
    Liu C; Tsao MS; Grisham JW
    Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of growth factors in human pituitary.
    Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
    Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes.
    Vivien D; Galéra P; Lebrun E; Loyau G; Pujol JP
    J Cell Physiol; 1990 Jun; 143(3):534-45. PubMed ID: 2358472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
    Yamaoka K; Hirai R; Tsugita A; Mitsui H
    J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.